Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis.
about
Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy.Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trialsTreatment of breast cancer in young women: do we need more aggressive therapies?Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death.Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy.Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy
P2860
Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Efficacy of adjuvant chemother ...... ast cancer: a pooled analysis.
@ast
Efficacy of adjuvant chemother ...... ast cancer: a pooled analysis.
@en
type
label
Efficacy of adjuvant chemother ...... ast cancer: a pooled analysis.
@ast
Efficacy of adjuvant chemother ...... ast cancer: a pooled analysis.
@en
prefLabel
Efficacy of adjuvant chemother ...... ast cancer: a pooled analysis.
@ast
Efficacy of adjuvant chemother ...... ast cancer: a pooled analysis.
@en
P2093
P2860
P356
P1476
Efficacy of adjuvant chemother ...... ast cancer: a pooled analysis.
@en
P2093
Cornelis J H van de Velde
European Organization for Research and Treatment of Cancer
J Sven D Mieog
Jos A van der Hage
P2860
P2888
P356
10.1186/BCR1778
P577
2007-01-01T00:00:00Z
P5875
P6179
1025747325